Page last updated: 2024-08-22

galactosamine and pyrazolanthrone

galactosamine has been researched along with pyrazolanthrone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyagi, Y; Honda, Y; Ichida, T; Matsuda, Y; Suzuki, K; Takamura, M; Tamura, Y; Yamagiwa, S1
Galle, PR; He, YW; Kohl, T; Kreft, A; Nagel, M; Schattenberg, JM; Schuchmann, M; Schulze Bergkamen, H; Siebler, J; Sprinzl, MF; Wörns, M; Zimmermann, T1

Other Studies

2 other study(ies) available for galactosamine and pyrazolanthrone

ArticleYear
An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
    Life sciences, 2007, Mar-13, Volume: 80, Issue:14

    Topics: Alanine Transaminase; Animals; Anthracenes; Apoptosis; Aspartate Aminotransferases; bcl-Associated Death Protein; BH3 Interacting Domain Death Agonist Protein; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Enzyme Inhibitors; Galactosamine; Hepatocytes; Injections, Intraperitoneal; Injections, Subcutaneous; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Failure; Longevity; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Proto-Oncogene Proteins

2007
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
    Journal of hepatology, 2011, Volume: 55, Issue:6

    Topics: Animals; Anthracenes; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Chemical and Drug Induced Liver Injury; Concanavalin A; fas Receptor; Female; Galactosamine; Hepatocytes; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Mice, Knockout; Receptors, Death Domain

2011